Drugmaker GlaxoSmithKline has agreed to settle with plaintiffs for a total of $195 million over allegations that it monopolized the market for its nasal spray Flonase.
Font Size: 
GSK Agrees to Settle Flonase Antitrust Actions for $195 Mil.
The Legal Intelligencer
December 19, 2012
This article requires free registration
This article requires free registration to Law.com. Please sign in or register to read the full text.
